Cardiol Therapeutics Inc. (CRDL)

NASDAQ: CRDL · Real-Time Price · USD

1.14

0.02 (1.79%)

At close: May 02, 2025, 3:59 PM

1.10

-3.46%

After-hours: May 02, 2025, 04:31 PM EDT

Cardiol Therapeutics Balance Sheet Statement

Financials in CAD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	30.58M	34.93M	59.47M	83.9M	14.03M	6.96M	16.73M	2.36M
Short-Term Investments	n/a	61.88K	61.88K	61.57K	61.51K	61.2K	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	-0.00	-0.00	0.00	-0.00	n/a	n/a
Receivables	361.62K	n/a	n/a	407.13K	n/a	n/a	460.78K	101.75K
Inventory	n/a	n/a	n/a	n/a	17.97K	1.12M	6.35M	n/a
Other Current Assets	n/a	279.87K	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	31.67M	36.15M	61.44M	87.14M	14.95M	14.37M	24.03M	2.48M
Property-Plant & Equipment	195.59K	337.06K	295.74K	356.49K	479.55K	584.05K	25.55K	18.81K
Goodwill & Intangibles	n/a	210.36K	294.8K	379.25K	463.69K	548.13K	632.58K	717.02K
Total Long-Term Assets	195.59K	547.42K	590.54K	735.74K	943.24K	1.13M	658.13K	735.83K
Total Assets	31.86M	36.7M	62.03M	87.88M	15.89M	15.5M	24.68M	3.22M
Account Payables	n/a	7.62M	8.35M	4.14M	1.77M	561.29K	1.99M	165.41K
Deferred Revenue	n/a	n/a	-8.35M	-4.19M	-1.77M	-561.29K	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	6.98M	238.18K	419.9K	6.66M	0.00	78.79K	153.89K	11.3K
Total Current Liabilities	7.01M	8.3M	9.8M	11.57M	2.52M	690.55K	2.14M	176.71K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	269.22K	190.04K
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	125.52K	158.53K	22.42K	72.87K	104.65K	140.28K	269.22K	190.04K
Total Liabilities	7.14M	8.45M	9.83M	11.64M	2.62M	830.83K	2.41M	366.76K
Total Debt	158.53K	174.34K	72.87K	117.58K	156.57K	190.75K	269.22K	190.04K
Common Stock	179.34M	148.52M	147.55M	142.92M	51.92M	39.41M	36.72M	4.26M
Retained Earnings	-179.25M	-142.58M	-114.45M	-83.52M	-51.88M	-31.24M	-17.55M	-1.66M
Comprehensive Income	n/a	3.52M	3.52M	4.18M	4.46M	1.73M	1.85M	259.46K
Shareholders Equity	24.73M	28.25M	52.2M	76.24M	13.27M	14.67M	22.27M	2.85M
Total Investments	n/a	61.88K	61.88K	61.57K	61.51K	61.2K	n/a	n/a